CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-26 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,600 | $123.74 | $198K | 2,294,955 |
| 2024-06-26 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,500 | $124.90 | $187K | 2,293,455 |
| 2024-06-26 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,100 | $125.71 | $138K | 2,292,355 |
| 2024-06-26 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,100 | $127.50 | $140K | 2,291,255 |
| 2024-06-26 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,435 | $128.78 | $185K | 2,289,820 |
| 2024-06-26 | AFEYAN NOUBAR Director | Sale 10b5-1 | −2,300 | $129.84 | $299K | 2,287,520 |
| 2024-06-26 | AFEYAN NOUBAR Director | Sale 10b5-1 | −2,705 | $130.76 | $354K | 2,284,815 |
| 2024-06-26 | AFEYAN NOUBAR Director | Sale 10b5-1 | −700 | $131.56 | $92K | 2,284,115 |
| 2024-06-26 | AFEYAN NOUBAR Director | Sale 10b5-1 | −100 | $134.05 | $13K | 2,284,015 |
| 2024-06-18 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,700 | $132.22 | $225K | 2,312,315 |
| 2024-06-18 | AFEYAN NOUBAR Director | Sale 10b5-1 | −6,160 | $133.26 | $821K | 2,306,155 |
| 2024-06-18 | AFEYAN NOUBAR Director | Sale 10b5-1 | −6,840 | $134.09 | $917K | 2,299,315 |
| 2024-06-18 | AFEYAN NOUBAR Director | Sale 10b5-1 | −200 | $135.02 | $27K | 2,299,115 |
| 2024-06-18 | AFEYAN NOUBAR Director | Sale 10b5-1 | −100 | $136.92 | $14K | 2,299,015 |
| 2024-06-17 | Hoge Stephen President | Sale 10b5-1 | −15,000 | $138.16 | $2.1M | 1,457,089 |
| 2024-06-14 | Bancel Stephane Chief Executive Officer | Other acquisition | +26,840 | 5,487,064 | ||
| 2024-06-12 | AFEYAN NOUBAR Director | Sale 10b5-1 | −700 | $142.97 | $100K | 2,328,315 |
| 2024-06-12 | AFEYAN NOUBAR Director | Sale 10b5-1 | −408 | $144.46 | $59K | 2,327,907 |
| 2024-06-12 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,263 | $145.57 | $184K | 2,326,644 |
| 2024-06-12 | AFEYAN NOUBAR Director | Sale 10b5-1 | −3,031 | $146.55 | $444K | 2,323,613 |
Page 26 of 38 · 743 trades